TR200001892T2 - Monomer cinsi ensülin analogları ve bunların kullanımı. - Google Patents

Monomer cinsi ensülin analogları ve bunların kullanımı.

Info

Publication number
TR200001892T2
TR200001892T2 TR2000/01892T TR200001892T TR200001892T2 TR 200001892 T2 TR200001892 T2 TR 200001892T2 TR 2000/01892 T TR2000/01892 T TR 2000/01892T TR 200001892 T TR200001892 T TR 200001892T TR 200001892 T2 TR200001892 T2 TR 200001892T2
Authority
TR
Turkey
Prior art keywords
monomer
genus
insulin analogues
insulin analog
administration
Prior art date
Application number
TR2000/01892T
Other languages
English (en)
Inventor
Dennis Dimarchi Richard
Garrick Harrison Roger
Keith Wolff Ronald
Original Assignee
Eli Lilly And Company
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eli Lilly And Company filed Critical Eli Lilly And Company
Publication of TR200001892T2 publication Critical patent/TR200001892T2/tr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/28—Insulins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Diabetes (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Endocrinology (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Hematology (AREA)
  • Emergency Medicine (AREA)
  • Obesity (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Peptides Or Proteins (AREA)

Abstract

Mevcut bulus, diyabet tedavisi için, monomer cinsi bir ensülin analogunun solunum vasitasiyla verilmesini ve hiperglisemi için bir ensülin analogunun solunum vasitasiyla verilmesini içeren, bir ensülin analogunun solunumla kullanimi ile ilgilidir.
TR2000/01892T 1998-01-08 1999-01-07 Monomer cinsi ensülin analogları ve bunların kullanımı. TR200001892T2 (tr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US7075298P 1998-01-08 1998-01-08

Publications (1)

Publication Number Publication Date
TR200001892T2 true TR200001892T2 (tr) 2000-11-21

Family

ID=22097181

Family Applications (2)

Application Number Title Priority Date Filing Date
TR2000/01891T TR200001891T2 (tr) 1998-01-08 1999-01-07 ASPB28- İnsan ensülini ve kullanımı.
TR2000/01892T TR200001892T2 (tr) 1998-01-08 1999-01-07 Monomer cinsi ensülin analogları ve bunların kullanımı.

Family Applications Before (1)

Application Number Title Priority Date Filing Date
TR2000/01891T TR200001891T2 (tr) 1998-01-08 1999-01-07 ASPB28- İnsan ensülini ve kullanımı.

Country Status (16)

Country Link
US (2) US20010007853A1 (tr)
EP (2) EP0951910A3 (tr)
JP (2) JP2002500192A (tr)
KR (2) KR20010033941A (tr)
CN (2) CN1195543C (tr)
AU (2) AU754707B2 (tr)
BR (2) BR9906813A (tr)
CA (2) CA2317733A1 (tr)
EA (2) EA200000748A1 (tr)
HU (2) HUP0100391A3 (tr)
IL (2) IL137105A0 (tr)
NO (2) NO20003051D0 (tr)
PL (2) PL341592A1 (tr)
TR (2) TR200001891T2 (tr)
WO (2) WO1999034816A1 (tr)
ZA (2) ZA99105B (tr)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6131567A (en) * 1993-01-29 2000-10-17 Aradigm Corporation Method of use of monomeric insulin as a means for improving the reproducibility of inhaled insulin
US20060171899A1 (en) * 1998-12-10 2006-08-03 Akwete Adjei Water-stabilized aerosol formulation system and method of making
US6858199B1 (en) * 2000-06-09 2005-02-22 Advanced Inhalation Research, Inc. High efficient delivery of a large therapeutic mass aerosol
AU5453300A (en) * 1999-06-29 2001-01-31 Eli Lilly And Company Insulin crystals for pulmonary administration
US6458387B1 (en) * 1999-10-18 2002-10-01 Epic Therapeutics, Inc. Sustained release microspheres
US7374782B2 (en) 2000-10-27 2008-05-20 Baxter International Inc. Production of microspheres
EP1944016A1 (en) 2001-08-16 2008-07-16 Baxter International Inc. Propellant-based microparticle formulatons
PT1418890E (pt) * 2001-08-16 2008-06-09 Baxter Int Formulações de micropartículas à base de propulsor
US7641823B2 (en) * 2001-12-07 2010-01-05 Map Pharmaceuticals, Inc. Synthesis of small particles
AU2002359730A1 (en) * 2001-12-21 2003-07-30 Smithkline Beecham Corporation Compositions and methods for altering glucose production
US7677411B2 (en) 2002-05-10 2010-03-16 Oriel Therapeutics, Inc. Apparatus, systems and related methods for processing, dispensing and/or evaluatingl dry powders
US6985798B2 (en) * 2002-05-10 2006-01-10 Oriel Therapeutics, Inc. Dry powder dose filling systems and related methods
AU2003253792A1 (en) * 2002-06-27 2004-01-19 Oriel Therapeutics, Inc. Apparatus, systems and related methods for processing, dispensing and/or evaluating non-pharmaceutical dry powders
US20070277820A1 (en) * 2003-10-27 2007-12-06 Timothy Crowder Blister packages and associated methods of fabricating dry powder drug containment systems
US7377277B2 (en) * 2003-10-27 2008-05-27 Oriel Therapeutics, Inc. Blister packages with frames and associated methods of fabricating dry powder drug containment systems
US7451761B2 (en) * 2003-10-27 2008-11-18 Oriel Therapeutics, Inc. Dry powder inhalers, related blister package indexing and opening mechanisms, and associated methods of dispensing dry powder substances
WO2005065756A2 (en) 2003-12-30 2005-07-21 Oriel Therapeutics, Inc. Dry powder nebulizers and associated methods of dispensing dry powders
US7624733B2 (en) 2004-02-09 2009-12-01 Oriel Therapeutics, Inc. Inhalers with extendable/retractable forward member and associated methods of dispensing inhalant substances
CA2616997C (en) 2004-09-13 2014-12-23 Oriel Therapeutics, Inc. Dry powder inhalers that inhibit agglomeration, related devices and methods
WO2007024953A1 (en) * 2005-08-25 2007-03-01 Oriel Therapeutics, Inc. Drug containment systems with sticks, related kits, dry powder inhalers and methods
US7987845B2 (en) * 2006-01-31 2011-08-02 Oriel Therapeutics, Inc. Dry powder inhalers having spiral travel paths, unit dose microcartridges with dry powder, related devices and methods
EP2060268A1 (en) * 2007-11-15 2009-05-20 Novo Nordisk A/S Pharmaceutical compositions for pulmonary or nasal delivery of peptides
CN102159270B (zh) 2008-09-26 2014-07-02 奥里尔治疗公司 一种带有具有气道盘沟槽的气道盘的吸入器和相关的气道盘和方法
CA2732840C (en) 2008-09-26 2016-07-05 Oriel Therapeutics, Inc. Dry powder inhalers with dual piercing members and related devices and methods
WO2010036355A2 (en) 2008-09-26 2010-04-01 Oriel Therapeutics, Inc. Inhaler mechanisms with radially biased piercers and related methods
WO2010039200A2 (en) * 2008-09-30 2010-04-08 Oriel Therapeutics, Inc. Dry powder inhalers with endless strips and cooperating piercers and related methods
US9050427B2 (en) * 2008-09-30 2015-06-09 Oriel Therapeutics, Inc. Dry powder inhalers with multi-facet surface deagglomeration chambers and related devices and methods
ES2561899T3 (es) * 2008-10-01 2016-03-01 Oriel Therapeutics, Inc. Inhaladores de polvo seco con mecanismos de perforación giratorios y dispositivos y métodos relacionados
JP5341532B2 (ja) * 2009-01-19 2013-11-13 第一電子工業株式会社 １対の誤嵌合防止キー及び該キーを用いた電気コネクタ
CN101912600B (zh) * 2010-01-11 2014-01-29 杨国汉 改善胰岛素在溶液中稳定性的方法
US9056173B2 (en) 2010-01-27 2015-06-16 Aespira Ltd. Dry powder inhaler
USD635246S1 (en) 2010-03-26 2011-03-29 Oriel Therapeutics, Inc. Dose disk for dry powder inhalers
USD641076S1 (en) 2010-03-26 2011-07-05 Oriel Therapeutics, Inc. Dry powder inhaler
US10238820B2 (en) 2014-01-08 2019-03-26 Seroton, Inc. Dry-powder inhalation device
US11491288B2 (en) 2014-01-08 2022-11-08 Seroton, Inc. Dispenser for dry-powder inhalation devices
WO2024100652A1 (en) 2022-11-07 2024-05-16 Kritzman Kadron Amnon High performance dry powder inhaler

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK179286D0 (da) * 1986-04-18 1986-04-18 Nordisk Gentofte Insulinpraeparat
NZ232375A (en) * 1989-02-09 1992-04-28 Lilly Co Eli Insulin analogues modified at b29
US5230884A (en) * 1990-09-11 1993-07-27 University Of Wales College Of Cardiff Aerosol formulations including proteins and peptides solubilized in reverse micelles and process for making the aerosol formulations
US6131567A (en) * 1993-01-29 2000-10-17 Aradigm Corporation Method of use of monomeric insulin as a means for improving the reproducibility of inhaled insulin
JP2837956B2 (ja) * 1993-06-21 1998-12-16 ノボ ノルディスク アクティーゼルスカブ Ａｓｐ▲上Ｂ２８▼インスリン結晶
DK72793D0 (da) * 1993-06-21 1993-06-21 Novo Nordisk As Nyt produkt
TW402506B (en) * 1993-06-24 2000-08-21 Astra Ab Therapeutic preparation for inhalation
US5451569A (en) * 1994-04-19 1995-09-19 Hong Kong University Of Science And Technology R & D Corporation Limited Pulmonary drug delivery system
US5461031A (en) * 1994-06-16 1995-10-24 Eli Lilly And Company Monomeric insulin analog formulations
US5547929A (en) * 1994-09-12 1996-08-20 Eli Lilly And Company Insulin analog formulations
YU18596A (sh) * 1995-03-31 1998-07-10 Eli Lilly And Company Analogne formulacije monomernog insulina
EP0741188A3 (en) * 1995-05-05 1999-07-14 Eli Lilly And Company Single chain insulin with high bioactivity

Also Published As

Publication number Publication date
US20010007853A1 (en) 2001-07-12
CN1287492A (zh) 2001-03-14
AU2107399A (en) 1999-07-26
BR9906813A (pt) 2001-03-20
EA200000748A1 (ru) 2000-12-25
EP0951910A3 (en) 2002-06-19
TR200001891T2 (tr) 2000-11-21
JP2002500193A (ja) 2002-01-08
ZA99104B (en) 2000-07-07
AU754707B2 (en) 2002-11-21
HUP0101293A2 (hu) 2001-08-28
AU747619B2 (en) 2002-05-16
IL137150A0 (en) 2001-07-24
CN1287491A (zh) 2001-03-14
NO20003050L (no) 2000-06-14
CA2317739A1 (en) 1999-07-15
EP0951910A2 (en) 1999-10-27
NO20003051L (no) 2000-06-14
EA200000747A1 (ru) 2000-12-25
CA2317733A1 (en) 1999-07-15
CN1195543C (zh) 2005-04-06
PL342745A1 (en) 2001-07-02
NO20003050D0 (no) 2000-06-14
AU2312299A (en) 1999-07-26
HUP0100391A2 (hu) 2001-08-28
NO20003051D0 (no) 2000-06-14
EP0951911A2 (en) 1999-10-27
KR20010033941A (ko) 2001-04-25
HUP0100391A3 (en) 2001-12-28
ZA99105B (en) 2000-07-07
BR9906796A (pt) 2000-11-14
WO1999034815A1 (en) 1999-07-15
KR20010033940A (ko) 2001-04-25
US20010053761A1 (en) 2001-12-20
HUP0101293A3 (en) 2001-12-28
EP0951911A3 (en) 2002-06-19
IL137105A0 (en) 2001-06-14
JP2002500192A (ja) 2002-01-08
PL341592A1 (en) 2001-04-23
WO1999034816A1 (en) 1999-07-15

Similar Documents

Publication Publication Date Title
TR200001892T2 (tr) Monomer cinsi ensülin analogları ve bunların kullanımı.
MXPA05007470A (es) Metodo para reducir la morbilidad y mortalidad cardiovascular en pacientes prediabeticos y pacientes con diabetes de tipo 2.
DE69332856D1 (de) Haarnadelförmiges ribozym
TR200002855T2 (tr) Raloksifenin solunum yolu ile veya burundan uygulanması.
BRPI0207700B8 (pt) mistura de conjugados monodispersa, composição farmacêutica, e, uso de uma mistura substancialmente monodispersa de um conjugado de polipeptídeo de insulina-oligômero
SE0001899D0 (sv) New compounds
PT1079876E (pt) Aparelho medico para uso de um doente no auto-tratamento da diabetes
TR199902033T2 (tr) Diyabet için sülfonilura-glitazon sinerjik kombinasyonlari.
DE50015623D1 (de) Kovalent verbrückte insulindimere
DK1162982T3 (da) Anvendelse af stabiliserede oligonucleotider til fremstilling af et lægemiddel med antitumoral virkning
HUP0204109A2 (en) Oral preparations for diabetes
DK1259240T3 (da) Midler, såsom nikotinamid eller CADPR, til behandling af hudsygdomme
FI963277A0 (fi) Paramuunisuusinduktori, joka perustuu rokkoviruskomponenttien yhdistelmiin, menetelmä sen valmistamiseksi ja sen käyttö lääkeaineena
BRPI0414979A (pt) preparação sólida
DE69821498D1 (de) Verwendung von amifostin
AU7862401A (en) Pharmaceutical compostion comprising trkaig2 for use in the prevention and/or treatment of cancer
WO1999051256A3 (en) Use of l-glu-l-trp in the treatment of hiv infection
IT1317930B1 (it) Uso della pentraxina lunga ptx3 per la preparazione di un medicamentoper il trattamento di patalogie associate ad una alterata attivazione
MXPA04001912A (es) Aminobenzofenonas novedosas.
BR0213183A (pt) Uso de ativadores gp130 em neuropatia diabética
BR9813098A (pt) Uso de glicosaminoglicans, preparação farmacêutica, e, combinaçào
AU2002225097A1 (en) Novel therapeutic use of a thienylcyclohexylamine derivative
TR200000728T2 (tr) Kronik hepatit C' nin tedavisinde IFN-alfa ve amantadin kullanımı.
BR0309375A (pt) Tratamento de sìndrome metabólica
PE20010226A1 (es) Uso de interferon modificado con peg para la preparacion de un medicamento para el tratamiento de leucemia mielocitica cronica